SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-229029
Filing Date
2014-06-09
Accepted
2014-06-06 18:20:52
Documents
1
Effectiveness Date
2014-06-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A d738740ddefa14a.htm DEFA14A 17167
  Complete submission text file 0001193125-14-229029.txt   18251
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-23265 | Film No.: 14897796
SIC: 2834 Pharmaceutical Preparations